期刊文献+

后纵隔血管滤泡性淋巴结增生症1例并文献复习

A case report of Castleman's disease of the posterior mediastinum and literature review
下载PDF
导出
摘要 血管滤泡性淋巴结增生症,又称Castleman's Disease(CD)、巨淋巴结增生症,是一种罕见的原因不明的慢性淋巴组织增生性疾病,主要以慢性渐进性淋巴结肿大为特征。该病误诊率较高,确诊有赖于病理检查。本例为1例46岁男性患者,因体检发现后纵膈占位1年入院,初诊为"后纵隔肿瘤;畸胎瘤?",拟行胸腔镜辅助下纵隔肿瘤切除术,术中切除困难,出血量多,中转开胸后成功切除肿块。术后病理提示血管滤泡性淋巴结增生症,透明血管型,随访10个月未见复发证据。该病例手术效果虽满意,但如术前即可明确诊断并了解肿瘤特性,可减少术中对患者造成的损害,遂复习相关文献并进行分析、总结。 Vascular follicular lymphadenopathy, also known as Castleman 's Disease(CD), giant lymph node hyperplasia, it is a rare cause of chronic lymphoproliferative dysplasia, mainly characterized by chronic progressive lymphadenopathy. The disease misdiagnosis rate is higher, the diagnosis depends on pathological examination. The case is a 46-year-old male patients, due to physical examination found mediastinal lumps a year, newly diagnosed as "posterior mediastinal tumor; teratoma?", intended thoracoscopic assisted mediastinal tumor resection. Because the surgery is difficult to remove lumps, bleeding more, the surgery decided to thoracotomy and successful removal of the mass. Postoperative pathology of vascular follicular lymphadenopathy, hyaline type, follow-up 10 months no recurrence of evidence. Although the operation of the case is satisfactory, but if the diagnosis can be clear before surgery and understand the characteristics of the tumor can reduce the damage caused by patients during surgery, so we review the relevant literature, analysis,and have a summary.
出处 《中国医药导报》 CAS 2017年第24期189-192,共4页 China Medical Herald
关键词 血管滤泡性淋巴结增生症 巨淋巴结增生症 后纵隔肿瘤 免疫组织化学 Castleman's disease Giant lymph node hyperplasia Posterior mediastinal neoplasms Immunohistochemistry
  • 相关文献

参考文献8

二级参考文献65

  • 1Casper C. The aetiology and management of Castleman disease at 50 years:Translating pathophysiology to patient care [J]. Br J Heamatol, 2005,129 ( 1 ) : 3-17.
  • 2Dispenzieri A, Gertz MA. Treatment of Castleman's disease [J]. Curr Treat Options Oncol, 2005,6(3) :255-266.
  • 3Bowne WB, Lewis J J, Filippa DA, et al. The management of unicentric and muhicentric Castleman's disease: A report of 16 cases and a review of the literature [ J ]. Cancer, 1999,85 (3) : 706-717.
  • 4Chronowski GM, Ha CS, Wilder RB, et al. Treatment of unicentric and muhicentric Castleman disease and the role of radiotherapy [J]. Cancer, 2001,92(3) :670-676.
  • 5Nishimoto N, Kanakura Y, Aozasa K, et al. Humanized antiinterleukin-6 receptor antibody treatment of muhicentric Castleman disease[J]. Blood, 2005,106(8) :2627-2632.
  • 6Frizzera G. Castleman's disease and related disorders[J]. Semin Diagn Pathol, 1988:5 (4) : 346-364.
  • 7Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol, 1988,5 (4) : 346-364.
  • 8Bowne WB, Lewis J-J, Filippa DA, et al. The management of unicentric and muhicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer, 1999,85 (3) : 706- 717.
  • 9Castleman B, Iverson L, Menendex VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer, 1956, 9 : 822-830.
  • 10Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer, 1972, 29 : 670-683.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部